NCT06383364

Brief Summary

To examine the effect of a Medication Coordinator, who facilitates medication reviews in close collaboration with patients using My Medication Plan to reduce the risk of post-hospital inappropriate medication usage.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 25, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

July 14, 2025

Status Verified

July 1, 2025

Enrollment Period

1.7 years

First QC Date

March 18, 2024

Last Update Submit

July 11, 2025

Conditions

Medication ReviewPolypharmacyPotentially Inappropriate MedicationQuality of LifeMedication Therapy Management

Keywords

PolypharmacyMedication reviewPatient care managementEmpowermentPotentially inappropriate medication listHospital to home transitionMedication qualitymedication optimizationTreatment burden

Outcome Measures

Primary Outcomes (1)

  • Change in potentially inappropriate medication according to Potentially Inappropriate Medication List

    Evaluating the patients drug treatment to assess if a drug is a potentially inappropriate medication

    Baseline and 6 months

Secondary Outcomes (6)

  • Evaluation of patients experiences quality of life with the EQ-5D and EQ-VAS.

    Baseline and 3 months

  • Evaluation of patients experienced quality of life with visual analogue scale (VAS).

    Baseline and 3 months

  • Evaluation of patients experienced treatment burden with the questionnaire Multimorbidity treatment burden questionnaire (MTBQ).

    Baseline and 3 months

  • Evaluation of patients experienced medication burden with visual analogue scale (VAS).

    Baseline and 3 months

  • Patient readmission 30 days after hospital discharge

    30 days after the patient has been discharged from the hospital.

  • +1 more secondary outcomes

Study Arms (2)

Interventions group

ACTIVE COMPARATOR

The Medication Coordinator facilitates the medication reviews in close collaboration with the patients by applying concepts of motivational interview in combination with My Medication Plan

Behavioral: Medication Coordinator

Control group

NO INTERVENTION

Usual treatment from a team consisting of hospital physicians, nurses, nurse assistants, and as needed occupational therapists, physiotherapist, and clinical dieticians. Medication reconciliation might be a part of the patients' usual care performed by physicians or pharmacologist present at the acute ward. Hospital physicians and/or nurses might perform patient counselling about medication treatment during hospitalization

Interventions

Medication CoordinatorBEHAVIORAL

The Medication Coordinator calls the patient app seven days after discharge in the transition of care from hospital to home

Interventions group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • all hospitalized patients, who are prescribed at least five medications specified in the Electronic Patient Journal (EPJ) used at ward

You may not qualify if:

  • unable to communicate in Danish, cognitively impaired e.g. suffering from dementia or Alzheimer's, or cannot cooperate due to e.g. hallucination or aggressive behavior

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sygehus Sønderjylland

Aabenraa, Southern Denmark, 6200, Denmark

Location

Related Publications (1)

  • Schlunsen M, Graabaek T, Pedersen AK, Kampmann JD, Kjeldsen LJ. Study protocol: The effect of a Medication Coordinator on the quality of patients' medication treatment (MEDCOOR)-Randomized controlled trial. PLoS One. 2024 Nov 26;19(11):e0314023. doi: 10.1371/journal.pone.0314023. eCollection 2024.

    PMID: 39591420DERIVED

MeSH Terms

Conditions

Empowerment

Condition Hierarchy (Ancestors)

Social BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2024

First Posted

April 25, 2024

Study Start

June 1, 2024

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

July 14, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations

DK(1)